Exponential growth of systematic reviews assessing artificial intelligence studies in medicine: challenges and opportunities
- PMID: 35761303
- PMCID: PMC9238033
- DOI: 10.1186/s13643-022-01984-7
Exponential growth of systematic reviews assessing artificial intelligence studies in medicine: challenges and opportunities
Abstract
The evidence-based medicine (EBM) movement is stepping up its efforts to assess medical artificial intelligence (AI) and data science studies. Since 2017, there has been a marked increase in the number of published systematic reviews that assess medical AI studies. Increasingly, data from observational studies are used in systematic reviews of medical AI studies. Assessment of risk of bias is especially important in medical AI studies to detect possible "AI bias".
Keywords: Artificial intelligence; Evidence-based medicine; Systematic reviews.
© 2022. The Author(s).
Conflict of interest statement
The authors declare that they have no competing interests.
Figures
References
-
- DeBrusk C. The risk of machine-learning bias (and how to prevent it). MIT Sloan Manag Rev. 2018.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
